BIOTECHNOLOGY

IMS001 was derived from the pluripotential cell line designated ESI-053 licensed from AgeX Therapeutics.

With the updated guidance from FDA issued on March 16, BGI's detection kit is eligible to be used immediately to expedite clinical testing for the novel coronavirus.

The phase 2 clinical trial of RLF-100 (Aviptadil) is being coordinated with the Senior Leadership of the Government of Israel for the treatment of Acute Respiratory Distress Syndrome in patients with COVID-19 infection. The trial is being coordinated by Prof. Jonathan Javitt, MD, MPH, acting Chairman of the Scientific Advisory Board of Relief in coordination with Dr. Miki Halberthal, MD, CEO of the Rambam Healthcare Campus and Dr. Boaz Lev, head of Israel’s COVID task force and former Director-General of Israel’s Ministry of Health.

As the only FDA-inspected lab of its type in the region, Agilex Biolabs is located in Adelaide, South Australia, in a science and biotech specialist hub. The company specializes in bioanalysis for small molecules and biologics for PK, immunogenicity, and biomarkers utilizing the two platforms of LC-MS/MS and Immunoassay (MesoScale, Gyrolab).

CEL-SCI notes the LEAPS peptides will utilize conserved regions of coronavirus proteins to stimulate protective cell-mediated T cell responses and reduce viral load.

"We have been working on multiple solutions to augment our NxTAG and ARIES offerings in order to facilitate and automate the detection of SARS-CoV-2," said Nachum "Homi" Shamir, President and CEO of Luminex.

The Quantum-Si ecosystem encompasses everything required to decode the molecules of life, including sample preparation, sequencing, and data analysis. The transition from analog to digital proteomics enables a new generation of more sensitive and accurate research tools and diagnostics.

EndoClot SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of polyps, adenomas, early-stage cancers, and other GI mucosal lesions.